Trial Profile
Prospective, multi-centre, randomized, double-blind, two-arm, parallel group, active-control, comparative clinical study to evaluate pharmacokinetic, efficacy and safety of R-TPR-018/ Enbrel in Patients with Active Rheumatoid Arthritis on a stable dose of Methotrexate
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Reliance Life Sciences
- 09 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Feb 2017 Status changed from not yet recruiting to recruiting.
- 06 Sep 2016 New trial record